Onconova Therapeutics, Inc.·4

Dec 14, 9:00 AM ET

OLER ABRAHAM N. 4

4 · Onconova Therapeutics, Inc. · Filed Dec 14, 2020

Insider Transaction Report

Form 4
Period: 2020-12-11
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
  • Purchase

    Common Stock

    2020-12-11$0.32/sh+30,000$9,600140,000 total
Footnotes (1)
  • [F1]Includes 65,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -